ERBB2 and ductal breast carcinoma in situ: The majority (8/10) of the false negative lesions were either non-invasive cancers (DCIS, n = 6) or low-risk invasive cancers (luminal A type, i.e., ER-/PR-positive, Her2-negative, and low proliferation index Ki-67; n = 2).